spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Exelixis 

 HSMN NewsFeed - 17 May 2021
Soteria Biotherapeutics Launches with $42 Million Series A Financing Led by Roche Venture Fund and 5AM Ventures
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 5 Mar 2021
PACT Pharma Announces Planned Retirement of CEO Alex Franzusoff; Veteran Biotech Executive Scott Garland Named as Successor
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 May 2020
Sutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Aug 2018
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 5 Jun 2018
IDEAYA Biosciences Appoints Paul Stone, J.D., as Senior Vice President and General Counsel, Head of Operations and Mark Lackner, Ph.D. as Vice President, Head of Biomarkers and Synthetic Lethal Biology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Mar 2018
PMV Pharma Appoints Salim Yazji, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jan 2018
Denovo Biopharma Opens New R&D Center, Names Chief Medical Officer and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2017
Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2017
Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2017
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Jul 2017
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 14 Sep 2016
European Commission Approves CABOMETYX(TM) (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted Therapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 Feb 2016
Alder BioPharmaceuticals Strengthens and Expands Leadership Team Supporting Advancement of ALD403 Toward Future Commercialization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2015
Exelixis Announces Positive Overall Survival Results from Phase 3 Pivotal Trial of Cobimetinib in Combination with Vemurafenib in Patients with BRAF V600 Mutation-Positive Advanced Melanoma
Biopharmaceuticals Oncology Dermatology
 HSMN NewsFeed - 16 Jul 2015
Exelixis Appoints Chris Senner as Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2015
Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 23 Feb 2015
Compugen Expands and Strengthens Business Development Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Feb 2015
FDA Grants Genentech’s Cobimetinib Priority Review for Use in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Jul 2014
Genentech’s Investigational Medicine Cobimetinib, Used in Combination with Zelboraf(R) (Vemurafenib), Helped People with Advanced Melanoma Live Significantly Longer Without Their Disease Worsening
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Mar 2014
Exelixis Receives Approval for COMETRIQ(R) (Cabozantinib) in the European Union for Treatment of Progressive, Unresectable Locally Advanced or Metastatic Medullary Thyroid Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Jan 2014
A.P. Pharma Announces Appointment of New Directors and Effective Date of Name Change and Reverse Stock Split
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 23 May 2013
Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2011
Exelixis Appoints Executive Vice President and Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Mar 2011
Lilly Announces New Vice President of Oncology Research
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Jan 2011
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Oct 2010
Exelixis Licenses Programs to Bristol-Myers Squibb Company
Biopharmaceuticals Licensing
 HSMN NewsFeed - 26 Aug 2010
XOMA Appoints Jack L. Wyszomierski to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2010
Aragon Pharmaceuticals Appoints Richard A. Heyman CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Jun 2010
Exelixis Regains Full Rights to Develop and Commercialize XL184
Biopharmaceuticals
 HSMN NewsFeed - 5 Oct 2009
NeuroTherapeutics Pharma Appoints Dr. Corey Goodman to Its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Jul 2009
Nuon Therapeutics Appoints Paulette Dillon, Chief Business Officer, and Tito Serafini, Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2009
Limerick BioPharma Raises $15 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Apr 2009
Jazz Pharmaceuticals, Inc. Announces Board of Directors and Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2008
Bristol-Myers Squibb and Exelixis Enter Global Collaboration on Two Novel Cancer Programs
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Sep 2008
Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2008
Biogen Idec Announces Slate of Directors for Annual Meeting of Shareholders
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2008
Exelixis and Bristol-Myers Squibb to Co-Develop XL139, an Inhibitor of the Hedgehog Pathway
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Jan 2008
GSK Does Not Option XL784 for Further Development
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Jan 2008
Exelixis Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2007
VistaGen Names Agustin de la Calle, Ph.D. as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2007
OncoMed Appoints William D. Waddill Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Oct 2007
Dr. Martin Mackay Named President of Pfizer Global Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2007
Hana Biosciences Appoints S. Michael Imperiale, Jr., M.D., as Vice President, Clinical Research Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Aug 2007
GlaxoSmithKline Accelerates Review of Exelixis' XL880
Biopharmaceuticals
 HSMN NewsFeed - 14 Jun 2007
Anacor Names Paulette Dillon as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2007
Exelixis Reports Integrated Data From Phase II Clinical Trials of XL999 at ASCO
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Apr 2007
James M. Cornelius Elected Bristol-Myers Squibb CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2007
Exelixis Reinitiates Clinical Development of XL999 in Patients With Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Apr 2007
Exelixis Appoints Experienced Clinician and Scientist to Vice President of Translational Medicine
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Mar 2007
Exelixis Files IND Application for XL147
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jan 2007
Exelixis Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2007
Kosan Appoints Jane Green as Vice President, Corporate Communications
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2007
Exelixis Signs Co-Development Agreement With Genentech for Small Molecule Oncology Compound
Biopharmaceuticals
 HSMN NewsFeed - 22 Dec 2006
Company Announces Acquisition of Research and Development Programs, Hiring of Senior Management Team and Name Change
Biopharmaceuticals Acquisitions Personnel
 HSMN NewsFeed - 18 Dec 2006
Exelixis and Bristol-Myers Squibb Sign New Collaboration Agreement to Discover and Develop Novel Oncology Compounds
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Nov 2006
Exelixis Suspends Enrollment of New Patients in XL999 Phase II Clinical Trial Program
Biopharmaceuticals
 HSMN NewsFeed - 26 Oct 2006
Ilypsa Announces Appointment of William D. Waddill as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2006
Kalypsys Appoints 2 Executives to Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jun 2006
Exelixis Appoints Experienced Biotechnology Executive as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2006
Poniard Pharmaceuticals Announces Management Changes
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 36

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 36 additional stories matching:
Exelixis
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.